Combining Myeloma Vaccines and T Cell Therapies - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Combining Myeloma Vaccines and T Cell Therapies with Stem Cell Transplant with Dr. Muzaffar Qazilbash, MD, MD Anderson Cancer Center

Combining Myeloma Vaccines and T Cell Therapies with Stem Cell Transplant with Dr. Muzaffar Qazilbash, MD, MD Anderson Cancer Center image

Combining Myeloma Vaccines and T Cell Therapies with Stem Cell Transplant with Dr. Muzaffar Qazilbash, MD, MD Anderson Cancer Center

Podcast
event Feb 25, 2016 / 11:00AM MST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Muzaffar Qazilbash, MD MD Anderson Cancer Center Interview Date: February 25, 2016 

 Immunotherapies are the "next big thing" in multiple myeloma care but it may be too early to have them replace effective treatments like autologous stem cell transplant, iMiDs and proteasome inhibitors. Dr. Muzaffar Qazilbash, MD of MD Anderson Cancer Center shares how the new treatments will be added to current therapies to make outcomes even better for patients with this aggressive cancer. Using the new tools available can potentially offer longer remission times to standard therapy without adding extra toxicity. Dr. Qazilbash shares his most recent study to use a personalized vaccine together with a T Cell treatment and stem cell transplant. The vaccine is personalized based on a patient's own type of myeloma. Additionally, the patient's T cells are removed, grown and expanded in the lab. Following a normal autologous stem cell transplant, the vaccine is administered and the expanded T Cells are given back. This is just one way in which the new immunotherapy approaches can boost the impact of tried and true treatments. 

multiple myeloma 

Thanks to our Episode Sponsor, Takeda Oncology

Schedule & Agenda

Event panelist Dr. Muzaffar Qazilbash & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Muzaffar Qazilbash & Jenny Ahlstrom

Speakers & Moderators

The panelist Muzaffar Qazilbash, MD
Muzaffar Qazilbash, MD

Mazaffar Qazilbash, MD, is Director of Myeloma Transplantation and Cellular Therapy and Professor in the Department of Stem Cell Transplantation in the Division of Cancer Medicine at the MD Anderson Cancer Center in Houston, TX. His primary research interests are stem cell transplantation for myeloma, cancer vaccines, and immunotherapy. Dr. Qazilbash served a fellowship in hematology and oncology at the National Heart, Lung, and Blood Institute in Bethesda, MD after residencies at the University of Connecticut and Wright State University in Dayton, OH. He earned his medical degree at the University of Karachi, Pakistan.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.